Harvard Bioscience (HBIO) Posts Q3 EPS of $0.04, Down Y/Y
Harvard Bioscience Inc. (NASDAQ: HBIO) reports Q3 EPS of $0.04, compared to $0.05 in the same quarter last year. Revenue for the quarter was $21 million, versus $20 million in Q08.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
